| | | | | | | | | | | | | | | | | | | | |
. | What do you make of the policy implications (8.4) in this social computing & health report? http://j.mp/1rJr2f | Andrew Spong | andrewspong | 27-Nov-2009 | | | | | | | | | | | | | | | | |
. | | | | | | | | | | | | | | | | | | | | |
. | | | | | | | | | | | | | | | | | | | | |
. | The 3C rule and its likelihood to get adopted by FDA. | Heather R. Powell | @heldincontempt | 20-Nov-2009 | Special session on FDA hearing hosted by H. Powell | | | | | | | | | | | | | | | |
. | Feasibility and likelihood of the “one-click” rule becoming true guidance | Heather R. Powell | @heldincontempt | 20-Nov-2009 | Special session on FDA hearing hosted by H. Powell | | | | | | | | | | | | | | | |
. | MedWatch and access to it could be improved. | Heather R. Powell | @heldincontempt | 20-Nov-2009 | Special session on FDA hearing hosted by H. Powell | | | | | | | | | | | | | | | |
. | What impact/role will SM have in CME globally | Lawrence Sherman | @meducate | 13-Nov-2009 | | | | | | | | | | | | | | | | |
. | What can EU healthcare learn from this week's FDA Social Media hearing? | Daniel Ghinn | @EngagementStrat | 12-Nov-2009 | FDA SM hearing will be ongoing but we should have a good feel for it by 13:00 CET Friday. Follow comment on Twitter with #fdasm, and live stream at http://www.capitolconnection.net/capcon/fda/111209/FDAlive.htm | | | | | | | | | | | | | | | |
. | Google, Yahoo call for expanded online drug ads; good for patients? | Aniko Lecoultre | @AnikoLecoultre | 12-Nov-2009 | http://finance.yahoo.com/news/Google-Yahoo-call-for-apf-4293379524.html?x=0&.v=3 | | | | | | | | | | | | | | | |
. | Experiences in EU of sites rating physicians and/or hospitals? Which are the constraints? | Pedro L. González | PedroLuisGS | 6-Nov-2009 | | | | | | | | | | | | | | | | |
. | What are most effective ways to build a healthcare (provider and patient) community? Are there any ressources available? | Bart de Witte | @swisshealth20 | 6-Nov-2009 | http://www.linkedin.com/groupAnswers?viewQuestionAndAnswers=&gid=2272161&discussionID=9319628&goback=.anh_2272161 | | | | | | | | | | | | | | | |
. | If DTC advertising to patients in EU is banned, but SM is global, can industry utilise SM to give EU patients info online (in keeping with the EC rules)? | Bethan Hughes | @hughesbethan @NatRevDrugDisc | 6-Nov-2009 | | | | | | | | | | | | | | | | |
. | Does the paid solicitation of user-generated content diminish the use value of social media for pharma? | Andrew Spong | @andrewspong | 30-Oct-2009 | See http://is.gd/4E5LG for background and a poll. This specifically refers to a project J&J announced on JNJ BTW in May that I totally missed at the time. | | | | | | | | | | | | | | | |
. | [How can we help pharma understand sidiwikis and what are the implications for managing engagement?] If Neil doesn't have another Q, I'd like to ask something @whydotpharma raised earlier in the week: questions "cult of personality" of corp blogger/tweeter. What happens when they leave? | Neil Crump | @aurorahealthpr | 30-Oct-2009 | Update: I tweeted Neil earlier today and asked if he'd mind posing another question as we addressed this on 2nd October | | | | | | | | | | | | | | | |
. | Do we need pan European social media health communities (like Sermo, PLM etc.) in order to become an “attractive“online/ social media market? | Silja Chouquet | @whydotpharma | 30-Oct-2009 | At epatcon Manhattan research said the EU less attractive market due to lack of pan Eu platforms, making it harder to monetize engagement - do you agree? Are there any pan EU networks, you know of? | | | | | | | | | | | | | | | |
. | Journal of Participatory Medicine: what value can it contribute? | e-Patient Dave | @ePatientDave | 23-Oct-2009 | Why does this Google Doc have no divider at the bottom of this row? Somebody fix it, please. [Andrew: fixed, by the looks of it, but for the aesthetically inclined, NB the borders drop-down, just below and to the right of the Help option above.] | | | | | | | | | | | | | | | |
. | I'd like to know EU's thoughts about medical records: how is EU different from US? | e-Patient Dave | @ePatientDave | 23-Oct-2009 | | | | | | | | | | | | | | | | |
. | What role will/should/can social media play in participatory medicine? | e-Patient Dave | @ePatientDave | 23-Oct-2009 | Are there opportunties to enlarge the Journal of Participatory Medicine to Europe? (<-- ooh, I like that!! - Cindy) Who says it's NOT enlarged to EU?? -Dave. [1] | | | | | | | | | | | | | | | |
. | The Health Care Social Media Europe Mission: your thoughts, suggestions, comments? | Silja Chouquet Andrew Spong | @whydotpharma @andrewspong | 16-Oct-2009 | | | | | | | | | | | | | | | | |
. | What are the equivalents of Sermo in the EU? Where do docs hang out? | Silja Chouquet | @whydotpharma | 16-Oct-2009 | | | | | | | | | | | | | | | | |